Summary by Futu AI
On December 31, 2023, Hudson Bay Capital Management LP, an investment management firm based in Delaware, and Sander Gerber, its managing member, filed an amended Schedule 13G/A with the SEC, indicating a change in their holdings of Conduit Pharmaceuticals Inc. The filing revealed that Hudson Bay Capital Management LP and Sander Gerber collectively own 73,078 shares of Conduit Pharmaceuticals' common stock, which are issuable upon the exercise of warrants. This represents 0.10% of the company's class of securities, based on 73,829,536 shares outstanding as of December 15, 2023. The shares are held by HB Strategies LLC, with the Investment Manager serving as the investment manager to HB Strategies LLC. Sander Gerber, as the managing member of Hudson Bay Capital GP LLC, which is the general partner of the Investment Manager, disclaims beneficial ownership of these securities. The filing also certifies that the securities were acquired in the ordinary course of business and not for the purpose of changing or influencing the control of Conduit Pharmaceuticals.